Home › Funds › TERRIL BROTHERS, INC. › GMED
TERRIL BROTHERS, INC. position in GMED
GLOBUS MED INC · Health Care
TERRIL BROTHERS, INC. reported holding 322,110 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$24.1M, representing 6.08% of its reported portfolio and ranking #7 among its reported holdings. TERRIL BROTHERS, INC. has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How TERRIL BROTHERS, INC.'s GMED position evolved
TERRIL BROTHERS, INC. first disclosed a stake in GMED in Q3 2023 at 53,915 shares (US$2.7M). The position peaked in Q4 2025 at 321,455 shares, worth US$28.1M. Across 13 filings, TERRIL BROTHERS, INC. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 322,110 shares valued at US$24.1M. Notable position changes include a 47% increase in Q4 2023 (shares were roughly flat over the following quarter), a 96% trim in Q1 2025 (shares fell 19% over the following quarter), a 7653% increase in Q2 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 53.91K | $2.68M | New |
| Q4 2023 | 79.36K | $4.23M | Add |
| Q1 2024 | 80.03K | $4.29M | Add |
| Q2 2024 | 79.08K | $5.42M | Reduce |
| Q3 2024 | 80.28K | $5.74M | Add |
| Q4 2024 | 79.95K | $6.61M | Hold |
| Q1 2025 | 3.27K | $239.73K | Reduce |
| Q2 2025 | 253.91K | $14.99M | Add |
| Q3 2025 | 321.97K | $18.44M | Add |
| Q4 2025 | 321.45K | $28.07M | Hold |
| Q1 2026 | 321.37K | $27.69M | Hold |
| Q2 2026 | 321.52K | $25.40M | Hold |
| Q3 2026 | 322.11K | $24.13M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M sh · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M sh · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
More on TERRIL BROTHERS, INC.
FAQ
How long has TERRIL BROTHERS, INC. held GMED?
TERRIL BROTHERS, INC. has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is TERRIL BROTHERS, INC.'s current position in GMED?
As of Q3 2026, TERRIL BROTHERS, INC. holds 322.11K shares of GMED (GLOBUS MED INC), valued at $24.13M, representing 6.08% of its reported portfolio and ranking #7.
Has TERRIL BROTHERS, INC. been buying or selling GMED?
In the latest 13F filing (Q3 2026), TERRIL BROTHERS, INC. held unchanged its position in GMED. The position peaked in Q4 2025 at 321.45K shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.